The Timbuktoo HealthTech Accelerator Program has launched a call to action for forward-thinking entrepreneurs and innovators throughout Africa, inviting them to present their revolutionary concepts aimed at reshaping healthcare across the continent.
This initiative is on the lookout for startups that offer scalable and sustainable solutions, utilizing technology to tackle pressing healthcare issues and support the achievement of the Sustainable Development Goals (SDGs).
With a focus on nurturing a vibrant startup ecosystem, the Timbuktoo HealthTech Accelerator Program is dedicated to supporting the development of cutting-edge healthcare innovations. These include AI-powered diagnostic tools, locally produced medical equipment, and biotechnological advancements specifically designed to meet the unique healthcare needs of the African population.
Criteria for Applicants:
- Technology-enabled solution: Startups must have a digital-first approach to their solutions.
- Contribution to SDGs: Solutions should align with and contribute to one or more of the UN SDGs.
- Scalability: Startups must have a clear path to growth and expansion.
- Defensibility: Startups should have a competitive advantage, such as intellectual property or domain expertise.
- Innovation: Startups must offer a novel approach to solving health challenges.
- Monetization strategy: Startups should have a clear plan for generating revenue.
Areas of Interest:
- Disease prevention
- Clinical preventive frameworks and community advocacy
- Vaccine and medicine production
- Medical robotics and automation
- Genomics
- Biomedical systems
- Patient care journey
- Pandemic/health emergencies management
- Malnutrition and stunting
Benefits for Selected Startups:
- Membership in the Timbuktoo HealthTech Hub ecosystem
- Mentorship from industry experts
- Equity-free funding of up to $100,000 USD
- Networking opportunities
- Access to investor networks
- Resources and support to accelerate growth
Application Process:
Interested startups can apply online here by October 6, 2024.
